Biopsia renal

1 Kitterer D, Guerzing K, Segerer S et al. Diagnostic impact of percutaneous renal biopsy. Clinical Nephrology 2015;84:311–22.

2  Prabhakar SS. Nephrology. In: Harward MP (ed). Medical secrets, 5th edn. Mosby, 2012:190–219.

3 National Institute for Health and Care Excellence. Urological cancers - recognition and referral. NICE, 2021. https://cks.nice.org.uk/ topics/urological-cancers-recognition-referral

4 National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management: Clinical guideline [CG182]. NICE, 2014. www.nice.org.uk/guidance/cg182

5 Cancer Research UK. Bladder cancer risk. Cancer Research UK, 2021. www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer/risk-factors#heading-Three

6 Cancer Research UK. Kidney cancer risk. Cancer Research UK, 2021. www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/kidney-cancer/risk-factors#heading-Three

7 Anderson J, Fawcett D, Feehally J et al. Joint consensus statement on the initial assessment of haematuria: Prepared on behalf of the renal association and British Association of Urological Surgeons. BAUS/RA, 2008:1–5.

8 McGregor D, Lynn K, Bailey R, Robson R, Gardner J. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. Clinical Nephrology 1998;49:345–8.

9 Richards N, Darby S, Howie A, Adu D, Michael J. Knowledge of renal histology alters patient management in over 40% of cases. Nephrology Dialysis Transplantation 1994;9:1255–9.

10 Topham P, Harper S, Furness P et al. Glomerular disease as a cause of isolated microscopic haematuria. QJM: An International Journal of Medicine 1994;87:329–35.

11 Vivante A, Afek A, Frenkel-Nir Y et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 2011;306:729–36.

12 Chan MM, Gale DP. Isolated microscopic haematuria of glomerular origin: clinical significance and diagnosis in the 21st century. Clin Med 2015;15:576.

13 Khanna R. Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome. Missouri Medicine 2011;108:33.

14 Floege J, Feehally J. Introduction to Glomerular Disease: Clinical Presentations. In: Floege J, Johnson RJ, Feehally J (eds). Comprehensive Clinical Nephrology, 4th edn. Mosby, 2010:193–207

15 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1–50.

16 Fogazzi GB. Urinalysis. In: Feehally J, Floege J, Tonelli M, Johnson RJ (eds). Comprehensive Clinical Nephrology. Elsevier, 2018:26–39.

17 Ingold CJ, Bhatt H. Orthostatic proteinuria. StatPearls, 2021.

18 Korneti PG, Tasic VB, Jovanoska LK, Korneti BK. Difference between orthostatic and march functional proteinuria by application of stress tolerance test and SDS–PAGE. Clin Chim Acta 2000;297:145–53.

19 NHS Digital. National Diabetes Audit - Report 2 Complications and Mortality, 2017-18. NHS, 2019.

20 Hill C, Cardwell C, Patterson C et al. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit. Diabetic Medicine 2014;31:448–54.

21 Sharma SG, Bomback AS, Radhakrishnan J et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clinical Journal of the American Society of Nephrology 2013;8:1718–24.

22 Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clinical Journal of the American Society of Nephrology 2017;12:2032–45.

23 De Zeeuw D, Remuzzi G, Parving H-H et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney International 2004;65:2309–20.

24 KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154.

25 Liang S, Zhang X-G, Cai G-Y et al. Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis. PloS One 2013;8:e64184.

26 Patel M, Clarke AM, Bruce IN, Symmons DP. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient. Arthritis Rheum 2006;54:2963–9.

27 Cervera R, Khamashta MA, Font J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 1993;72:113–24.

28 Moroni G, Vercelloni PG, Quaglini S et al. Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Annals of the Rheumatic Diseases 2018;77:1318–25.

29 Fanouriakis A, Kostopoulou M, Cheema K et al. 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ ERA–EDTA) recommendations for the management of lupus nephritis. Annals of the Rheumatic Diseases 2020;79:713–23.